Fig. 1 · Structure
Documents & Downloads
Terazosin
α1-Adrenoceptor Antagonist
Terazosin is a quinazoline derivative that functions as a competitive, orally active α1-adrenoceptor antagonist. It exerts its biological activity by promoting vasodilation and facilitating bladder relaxation. Terazosin is primarily utilized in research related to benign prostatic hyperplasia (BPH) and hypertension, making it a valuable tool in studies focused on these conditions.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Antagonist |
| CAS Number | 63590-64-7 |
| Applications | α1-Adrenoceptor Antagonist |
| Formula | C19H25N5O4 |
| Molecular Weight | 387.43 |
| SMILES | O=C(N1CCN(C2=NC(N)=C3C=C(OC)C(OC)=CC3=N2)CC1)C4OCCC4 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.